Stockscreener 앱 받기
20.07
1.83%
0.36
시간 외 거래:
20.18
0.11
+0.55%
전일 마감가:
$19.71
열려 있는:
$19.97
하루 거래량:
9.63M
Relative Volume:
1.12
시가총액:
$10.32B
수익:
$10.89B
순이익/손실:
$-241.00M
주가수익비율:
-75.56
EPS:
-0.2656
순현금흐름:
$340.00M
1주 성능:
-1.47%
1개월 성능:
+5.74%
6개월 성능:
-27.04%
1년 성능:
-36.95%
1일 변동 폭
$19.80
$20.45
1주일 범위
$19.36
$20.45
52주 변동 폭
$17.40
$37.74
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.07 | 10.13B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
525.81 | 185.65B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
206.04 | 58.74B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.02 | 40.09B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
45.96 | 36.03B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.35 | 37.85B | 5.26B | 1.44B | 1.76B | 9.7713 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Baxter International Inc. Stock: Hidden Health-Care Giant or Total Snooze Buy? - AD HOC NEWS
Baxter International (NYSE:BAX) Stock Rating Lowered by Zacks Research - MarketBeat
FOMO Trade: Is Baxter International Inc stock risky to hold nowJuly 2025 Fed Impact & Daily Price Action Insights - baoquankhu1.vn
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors - FinancialContent
What you need to know ahead of Baxter International's earnings release - MSN
Aug Chart Watch: Is Baxter International Inc in a long term uptrend2025 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Did Baxter’s New Dynamo Smart Stretcher Launch Just Shift Baxter International's (BAX) Investment Narrative? - Yahoo Finance
Baxter's Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand - PR Newswire
Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha
Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns - Yahoo Finance
How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story - Yahoo Finance
Big Picture: Will Baxter International Inc be affected by tariffsJuly 2025 Update & High Conviction Trade Alerts - baoquankhu1.vn
Sentiment Review: Is SEAT a top pick in the sectorQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Baxter International Stock: Quiet Turnaround Play Or Value Trap In Healthcare Tech? - AD HOC NEWS
What To Be Aware Of Before Baxter International Announces Its Earnings - Bitget
Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations - DirectorsTalk Interviews
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart.com
Sodium Chloride Injections Market, Global Forecast 2026-2032 - GlobeNewswire Inc.
The Bottom Fishing ClubBaxter: Defensive Pick, Restructuring And Paying Down Debt (BAX) - Seeking Alpha
Baxter International (NYSE:BAX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Baxter International (BAX) Faces Weak EPS Revision Grades - GuruFocus
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $23, Maintains Neutral Rating - marketscreener.com
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety - The Globe and Mail
Manning & Napier Advisors LLC Sells 51,029 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter introduces new hospital stretcher - MassDevice
Baxter International Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Baxter CEO outlines plan to slash debt, boost pipeline in 2026 - chicagobusiness.com
Baxter International Inc. Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in HospitalSettings - marketscreener.com
BaxterDynamo series is now available for order in the U.S. and is expected to be available during the first half of 2026 - marketscreener.com
IL-BAXTER-INTERNATIONAL - gazettextra.com
Baxter Introduces the Dynamo Series, A New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Baxter
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Business Wire
Does Baxter International (BAX) Now Look Fairly Priced After Multi‑Year Share Price Slide - Yahoo Finance
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Why Baxter (BAX) Stock Is Trading Lower Today - The Globe and Mail
Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside - DirectorsTalk Interviews
Stock Traders Buy Large Volume of Baxter International Put Options (NYSE:BAX) - MarketBeat
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges - Bioscience Association Manitoba
The Truth About Baxter International Inc.: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
SG Americas Securities LLC Grows Stock Holdings in Baxter International Inc. $BAX - MarketBeat
Barclays Cuts Baxter International (NYSE:BAX) Price Target to $30.00 - MarketBeat
Barclays Adjusts Price Target on Baxter International to $30 From $36, Maintains Overweight Rating - marketscreener.com
Baxter International Inc.: How a 90-Year Medtech Veteran Is Rebuilding Its Flagship Portfolio - AD HOC NEWS
A Look At Baxter International (BAX) Valuation After New MUSC Health Connected Care Partnership - Sahm
Why Baxter International Inc. stock is in analyst buy zoneJuly 2025 Reactions & Community Trade Idea Sharing Platform - ulpravda.ru
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Price Swings & Safe Capital Investment Plans - ulpravda.ru
Breakout Move: Can Baxter International Inc. stock attract ESG capital inflowsJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - ulpravda.ru
Will Baxter International Inc. stock outperform Nasdaq index2025 Major Catalysts & AI Optimized Trading Strategy Guides - ulpravda.ru
How strong is Baxter International Inc. stock revenue growthJuly 2025 WrapUp & AI Driven Price Predictions - ulpravda.ru
MUSC Health and Baxter partner to enhance patient care with technology - Investing.com Australia
Is Baxter International Inc. stock vulnerable to regulatory risksExit Point & Fast Moving Market Watchlists - ulpravda.ru
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
0.31%
자본화:
|
볼륨(24시간):